UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 396

Sortiert nach

Clinical utility of 30% relative decline in MRI-PDFF in predicting fibrosis regression in non-alcoholic fatty liver disease

Gut, 2022-05, Vol.71 (5), p.983

2022

Link zum Volltext

Verfügbarkeit prüfen

Letter: comparative diagnostic accuracy of magnetic resonance elastography vs. eight clinical prediction rules for non‐invasive diagnosis of advanced fibrosis in biopsy‐proven NAFLD – author's reply

Alimentary pharmacology & therapeutics, 2017-02, Vol.45 (3), p.479-479

Loomba, R.

2017

Link zum Volltext

Verfügbarkeit prüfen

Current Concepts, Opportunities, and Challenges of Gut Microbiome-Based Personalized Medicine in Nonalcoholic Fatty Liver Disease

Cell metabolism, 2021-01, Vol.33 (1), p.21-32

2021

Link zum Volltext

Verfügbarkeit prüfen

Editorial: first‐degree relatives of Mexican Americans with HCC are at increased risk of significant fibrosis—authors' reply

Alimentary pharmacology & therapeutics, 2023-05, Vol.57 (9), p.1038-1039

2023

Link zum Volltext

Verfügbarkeit prüfen

Review article: the emerging interplay among the gastrointestinal tract, bile acids and incretins in the pathogenesis of diabetes and non-alcoholic fatty liver disease

Alimentary pharmacology & therapeutics, 2012-11, Vol.36 (10), p.909-921

2012

Link zum Volltext

Verfügbarkeit prüfen

Non‐invasive screening of diabetics in primary care for NAFLD and advanced fibrosis by MRI and MRE

Alimentary pharmacology & therapeutics, 2016-01, Vol.43 (1), p.83-95

2016

Link zum Volltext

Verfügbarkeit prüfen

Meta-analysis: pioglitazone improves liver histology and fibrosis in patients with non-alcoholic steatohepatitis

Alimentary pharmacology & therapeutics, 2012-01, Vol.35 (1), p.66-75

2012

Link zum Volltext

Verfügbarkeit prüfen

Comparative diagnostic accuracy of magnetic resonance elastography vs. eight clinical prediction rules for non‐invasive diagnosis of advanced fibrosis in biopsy‐proven non‐alcoholic fatty liver disease: a prospective study

Alimentary pharmacology & therapeutics, 2015-06, Vol.41 (12), p.1271-1280

2015

Link zum Volltext

Verfügbarkeit prüfen

Review article: emerging anti‐fibrotic therapies in the treatment of non‐alcoholic steatohepatitis

Alimentary pharmacology & therapeutics, 2016-06, Vol.43 (11), p.1109-1123

2016

Link zum Volltext

Verfügbarkeit prüfen

Clinical, biochemical and histological differences between HIV‐associated NAFLD and primary NAFLD: a case–control study

Alimentary pharmacology & therapeutics, 2015-02, Vol.41 (4), p.368-378

2015

Link zum Volltext

Verfügbarkeit prüfen

Association between novel MRI‐estimated pancreatic fat and liver histology‐determined steatosis and fibrosis in non‐alcoholic fatty liver disease

Alimentary pharmacology & therapeutics, 2013-03, Vol.37 (6), p.630-639

2013

Link zum Volltext

Verfügbarkeit prüfen

Editorial: role of leucine‐metformin‐sildenafil combination in the treatment of nonalcoholic fatty liver disease (NAFLD)

Alimentary pharmacology & therapeutics, 2018-08, Vol.48 (3), p.378-379

2018

Link zum Volltext

Verfügbarkeit prüfen

Correlation between liver histology and novel magnetic resonance imaging in adult patients with non-alcoholic fatty liver disease - MRI accurately quantifies hepatic steatosis in NAFLD

Alimentary pharmacology & therapeutics, 2012-07, Vol.36 (1), p.22-29

2012

Link zum Volltext

Verfügbarkeit prüfen

Editorial: dark chocolate may improve NAFLD and metabolic syndrome by reducing oxidative stress

Alimentary pharmacology & therapeutics, 2016-09, Vol.44 (5), p.533-534

2016

Link zum Volltext

Verfügbarkeit prüfen

Editorial: further evidence for the use of advanced magnetic resonance imaging techniques to monitor NAFLD – authors’ reply

Alimentary pharmacology & therapeutics, 2017-05, Vol.45 (9), p.1271-1272

2017

Link zum Volltext

Verfügbarkeit prüfen

Clinical trial: pilot study of metformin for the treatment of non‐alcoholic steatohepatitis

Alimentary pharmacology & therapeutics, 2009-01, Vol.29 (2), p.172-182

2009

Link zum Volltext

Verfügbarkeit prüfen

Association between non-alcoholic fatty liver disease and decreased lung function in adults: A systematic review and meta-analysis

Diabetes & metabolism, 2019-12, Vol.45 (6), p.536-544

2019

Link zum Volltext

Verfügbarkeit prüfen

Assessment of treatment response in non‐alcoholic steatohepatitis using advanced magnetic resonance imaging

Alimentary pharmacology & therapeutics, 2017-03, Vol.45 (6), p.844-854

2017

Link zum Volltext

Verfügbarkeit prüfen

Editorial: non‐invasive assessment of hepatic fibrosis in alpha‐1 antitrypsin deficiency using magnetic resonance elastography – authors' reply

Alimentary pharmacology & therapeutics, 2016-09, Vol.44 (6), p.645-646

2016

Link zum Volltext

Verfügbarkeit prüfen

Editorial: the burden and aetiology of liver cirrhosis, and the risk of death

Alimentary pharmacology & therapeutics, 2016-07, Vol.44 (2), p.202-203

2016

Link zum Volltext

Verfügbarkeit prüfen

Editorial: non‐alcoholic fatty liver disease―a pandemic in need of novel treatments and endpoints

Alimentary pharmacology & therapeutics, 2017-07, Vol.46 (1), p.65-66

2017

Link zum Volltext

Verfügbarkeit prüfen

Synergistic association between alcohol intake and body mass index with serum alanine and aspartate aminotransferase levels in older adults: the Rancho Bernardo Study

Alimentary pharmacology & therapeutics, 2009-12, Vol.30 (11‐12), p.1137-1149

2009

Link zum Volltext

Verfügbarkeit prüfen

Editorial: obesity in chronic liver diseases – increased infections

Alimentary pharmacology & therapeutics, 2016-01, Vol.43 (2), p.311-312

2016

Link zum Volltext

Verfügbarkeit prüfen

Blood pressure levels and hypertension prevalence in a high selenium environment: results from a cross-sectional study

Nutrition, metabolism, and cardiovascular diseases, 2019-04, Vol.29 (4), p.398-408

2019

Link zum Volltext

Verfügbarkeit prüfen

Disruption of gut barrier integrity and host-microbiome interactions underlie MASLD severity in patients with type-2 diabetes mellitus

Gut microbes, 2024, Vol.16 (1), p.2304157-2304157

2024

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 396

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(369)
Mit Volltextzugriff
(363)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Englisch
(394)
Japanisch
(50)

Erscheinungsjahr

n.n

Thema

Science & Technology
(214)
Life Sciences & Biomedicine
(179)
Humans
(152)
Gastroenterology & Hepatology
(100)
Female
(80)
Male
(77)
Middle Aged
(59)
Adult
(53)
Pharmacology & Pharmacy
(49)
Biopsy
(42)
Liver Diseases
(41)
Fibrosis
(40)
Gastroenterology And Hepatology
(38)
Aged
(34)
Fatty Liver
(32)
Liver
(31)
Liver - Pathology
(30)
Hepatology
(28)
Risk Factors
(27)
Non-Alcoholic Fatty Liver Disease - Pathology
(26)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Clinical utility of 30% relative decline in MRI-PDFF in predicting fibrosis regression in non-alcoholic fatty liver disease

Letter: comparative diagnostic accuracy of magnetic resonance elastography vs. eight clinical prediction rules for non‐invasive diagnosis of advanced fibrosis in biopsy‐proven NAFLD – author's reply

Current Concepts, Opportunities, and Challenges of Gut Microbiome-Based Personalized Medicine in Nonalcoholic Fatty Liver Disease

Editorial: first‐degree relatives of Mexican Americans with HCC are at increased risk of significant fibrosis—authors' reply

Review article: the emerging interplay among the gastrointestinal tract, bile acids and incretins in the pathogenesis of diabetes and non-alcoholic fatty liver disease

Non‐invasive screening of diabetics in primary care for NAFLD and advanced fibrosis by MRI and MRE

Meta-analysis: pioglitazone improves liver histology and fibrosis in patients with non-alcoholic steatohepatitis

Comparative diagnostic accuracy of magnetic resonance elastography vs. eight clinical prediction rules for non‐invasive diagnosis of advanced fibrosis in biopsy‐proven non‐alcoholic fatty liver disease: a prospective study

Review article: emerging anti‐fibrotic therapies in the treatment of non‐alcoholic steatohepatitis

Clinical, biochemical and histological differences between HIV‐associated NAFLD and primary NAFLD: a case–control study

Association between novel MRI‐estimated pancreatic fat and liver histology‐determined steatosis and fibrosis in non‐alcoholic fatty liver disease

Editorial: role of leucine‐metformin‐sildenafil combination in the treatment of nonalcoholic fatty liver disease (NAFLD)

Correlation between liver histology and novel magnetic resonance imaging in adult patients with non-alcoholic fatty liver disease - MRI accurately quantifies hepatic steatosis in NAFLD

Editorial: dark chocolate may improve NAFLD and metabolic syndrome by reducing oxidative stress

Editorial: further evidence for the use of advanced magnetic resonance imaging techniques to monitor NAFLD – authors’ reply

Clinical trial: pilot study of metformin for the treatment of non‐alcoholic steatohepatitis

Association between non-alcoholic fatty liver disease and decreased lung function in adults: A systematic review and meta-analysis

Assessment of treatment response in non‐alcoholic steatohepatitis using advanced magnetic resonance imaging

Editorial: non‐invasive assessment of hepatic fibrosis in alpha‐1 antitrypsin deficiency using magnetic resonance elastography – authors' reply

Editorial: the burden and aetiology of liver cirrhosis, and the risk of death

Editorial: non‐alcoholic fatty liver disease―a pandemic in need of novel treatments and endpoints

Synergistic association between alcohol intake and body mass index with serum alanine and aspartate aminotransferase levels in older adults: the Rancho Bernardo Study

Editorial: obesity in chronic liver diseases – increased infections

Blood pressure levels and hypertension prevalence in a high selenium environment: results from a cross-sectional study

Disruption of gut barrier integrity and host-microbiome interactions underlie MASLD severity in patients with type-2 diabetes mellitus

Suchergebnisse filtern